Effect of continuous bioartificial kidney therapy on porcine multiple organ dysfunction syndrome with acute renal failure

ASAIO Journal

Volumn 53, Issue 3, 2007, Pages 329-334

  Huijuan, Mao ^a   Xiaoyun, Wang ^a   Xumin, Ying ^a   Hengjin, Wang ^a   Xia, Shen ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELL CULTURE; GROWTH KINETICS; IMPLANTS (SURGICAL); PATIENT TREATMENT; UREA;

ARTERIAL PRESSURE; BIOARTIFICIAL KIDNEY (BK); PORCINE MULTIPLE ORGAN DYSFUNCTION SYNDROMES; RENAL FAILURE;

ARTIFICIAL ORGANS;

CARBONIC ACID; CHROMIUM; INTERLEUKIN 10; INTERLEUKIN 6; POTASSIUM; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; ARTIFICIAL KIDNEY; BIOARTIFICIAL ORGAN; CONTROLLED STUDY; DISEASE MODEL; INTESTINE BIOPSY; MEAN ARTERIAL PRESSURE; MULTIPLE ORGAN FAILURE; NONHUMAN; OXYGEN TENSION; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; SWINE; UREA NITROGEN BLOOD LEVEL; URETER LIGATION;

ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HEMOFILTRATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES, PROXIMAL; KIDNEY, ARTIFICIAL; MULTIPLE ORGAN FAILURE; SURVIVAL RATE; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34249086504     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAT.0b013e3180590be5     Document Type: Article

References (16)

1. Kleinknecht D, Landais P, Brivet F, Loirat P: Prognosis and mortality in patients with multiple organ system failure. Ren Fail 18: 347-353, 1996.
2. Marshall JC: Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndromes. Crit Care Med 29: S99-S106, 2001. (Review)
3. Humes HD, Fissell WH, Weitzel WF, et al: Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Am J Kidney Dis 39: 1078-1087, 2002.
4. Humes HD, Buffington DA, MacKay SM, Funke AS, Weitzel WF: Replacement of renal function in uremic animals with a tissue-engineered kidney. Nat Biotechnol 17: 451-455, 1999.
5. Fissell WH, Lou L, Abrishimi S, Buffington DA, Humes HD: Bioartificial kidney ameliorates gram-negative bacteria-induced septic shock in uremic animals. J Am Soc Nephrol 14: 454-461, 2003.
6. Rodilla VR, Hawksworth GM: Isolation and culture of human renal cortical cells with characteristics of proximal tubules, in Jones GE (ed.) Methods in Molecular Medicine: Human cell culture protocols, Totowa NJ, Humana Press Inc.,1996, pp. 407-417.
7. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis: the ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644-1655, 1992.
8. Reid CL, Perrey C, Pravica V, Hutchinson IV, Campbell IT: Genetic variation in proinflammatory and anti-inflammatory cytokine production in multiple organ dysfunction syndrome. Crit Care Med 30: 2216-2221, 2002.
9. Ronco C, Tetta C, Mariano F, et al: Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 27: 792-801, 2003.
10. Kellum JA, Mehta RL, Angus DC, et al: The first international consensus conference on continuous renal replacement therapy. Kidney Int 62: 1855-1863, 2002.
11. Chapekar MS: Tissue engineering: challenges and opportunities. J Biomed Mater Res 53: 617-620, 2000. (Review)
12. Maguire PJ, Stevens C, Humes HD, et al: Bioartificial organ support for hepatic, renal, and hematologic failure. Crit Care Clin 16: 681-694, 2000.
13. Baugh JA, Bucala R: Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr Opin Drug Discov Devel 4: 635-650, 2001.
14. Yamada Y, Endo S, Kasai T, et al: Nuclear matrix protein, tumor necrosis factor-alpha, and nitrite/nitrate levels in patients with multiple organ dysfunction syndrome. Res Commun Mol Pathol Pharmacol 100: 92-104, 1998.
15. Lally K, Cruz E, Xue H: The role of anti-tumor necrosis factor-α and interleukin-10 in protecting murine neonates from Escherichia coli sepsis. J Pediatr Surg 35: 852-854, 2000.
16. Matsumoto T, Tateda K, Miyazaki S, et al: Effect of interleukin-10 on gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother 42: 2853-2857, 1998.